Status:

COMPLETED

Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid

Lead Sponsor:

University Hospital, Brest

Conditions:

Bullous Pemphigoid

Eligibility:

All Genders

18+ years

Brief Summary

Whereas pruritus is a major symptom in bullous pemphigoid, its characteristics and its impact on quality of life have been little studied. The objective of this study is to learn more about pruritus ...

Eligibility Criteria

Inclusion

  • adult
  • pruriginous bullous pemphigoid lately diagnosed.
  • Without PB treatment
  • MMS (Mini Mental State Examination) ≥ 21
  • In hospitalization or consultation

Exclusion

  • pregnant woman
  • nursing women

Key Trial Info

Start Date :

November 7 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 3 2018

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT03272958

Start Date

November 7 2017

End Date

October 3 2018

Last Update

January 7 2019

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

CH Argenteuil

Argenteuil, France, 95100

2

AP-HP, Hôpital Avicenne

Bobigny, France, 93009

3

CHU de Bordeaux

Bordeaux, France, 33404

4

CHRU de Brest

Brest, France, 29609